Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.44 |
| ▸ | TGM2 | P21980 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8937477 | 1.00 | KMT2A (0.54) | KMT2AMAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL8937476 | 1.00 | KMT2A (0.54) | KMT2AMAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL8937427 | 0.89 | KMT2A (0.64) | KMT2AMAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL8937423 | 0.89 | KMT2A (0.64) | KMT2AMAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL8937417 | 0.89 | KMT2A (0.64) | KMT2AMAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL8937577 | 0.85 | KMT2A (0.50) | KMT2AMAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL8937578 | 0.85 | KMT2A (0.50) | KMT2AMAPTRAB9ANPC1ALDH1A1 | |
| SCHEMBL8999026 | 0.81 | TSHR (0.47) | ALDH1A1TSHRP2RX7 | |
| SCHEMBL8999028 | 0.81 | TSHR (0.47) | ALDH1A1TSHRP2RX7 | |
| SCHEMBL8999022 | 0.81 | TSHR (0.47) | ALDH1A1TSHRP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5559109-A | Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist | SANKKO COMPANY, LIMITED (JP) | 1996-09-24 | — | — | US | disclosed |
| US-5556852-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| US-5369106-A | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists | SANKYO COMPANY, LIMITED (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5192766-A | Platelet activating factor antagonist | SANKYO COMPANY, LIMITED (JP) | 1993-03-09 | — | — | US | disclosed |